Pavan Asalapuram

AMR surveillance is failing less at the science layer than at the implementation layer. The diagnostic, data, and governance infrastructures needed to make One Health AMR detection operational across clinical, veterinary, and environmental settings remain fragmented and poorly integrated in most health systems.

I am a researcher in the Health Systems and Policy group, led by Professor Cecilia Stålsby Lundborg, at the Department of Global Public Health, Karolinska Institutet. My work sits at the intersection of translational diagnostics, One Health surveillance architecture, and health-system implementation, with a particular focus on how the EU–India health corridor can serve as a proof-of-concept model for integrated AMR surveillance that is scientifically rigorous and operationally feasible at scale.

My background spans two decades of developing and clinically validating diagnostic platforms for drug-resistant infections across Europe, Asia, and Africa, including work advanced into the WHO diagnostic evaluation pipeline for drug-resistant tuberculosis. This work has been supported by the Bill & Melinda Gates Foundation and EU research programmes, including H2020-MSCA-RISE and EU-COST.

My current research includes the development and clinical validation of SelektaDx™, a rapid multiplex molecular platform for AMR detection across human and veterinary health settings, alongside work on AI-enabled early-risk detection and implementation-aware decision systems within One Health frameworks.

I welcome collaboration with researchers, clinicians, public health practitioners, and policy professionals working on AMR, One Health diagnostics, and implementation policy at national and European levels.

My broader research and innovation interests sit at the intersection of diagnostics, One Health, implementation science, health systems, policy, and AI-enabled global health innovation.

I am particularly interested in how scientific and technological advances can be translated into accessible, scalable, and sustainable solutions for infectious diseases, antimicrobial resistance, and other major public health challenges.

My work is grounded in the view that meaningful progress in global health requires more than innovation alone. It requires strong partnerships, systems thinking, implementation pathways, and policy relevance.

Through this integrated approach, I aim to contribute to the next generation of tools and strategies that connect discovery, data, and real-world impact across diverse populations and health-system settings.

I have supervised approximately 20 Bachelor’s and Master’s thesis students and projects, taught laboratory practical courses at undergraduate and postgraduate levels, and delivered capacity-building workshops for clinicians and policymakers from India and China at the intersection of innovation, policy, and global health.